Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, has appointed Stephanie Fagan as its new Chief Corporate Affairs Officer. Fagan’s role will be pivotal in leading public affairs and corporate communications, especially as MindMed prepares to move its product candidate MM120 for generalized anxiety disorder into pivotal trials.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
